WGSWW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -7.6%
- Operating margin
- -10.6%
- Revenue growth YoY
- 26.5%
- Dividend yield
- —
- Beta
- 2.19
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
2 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About GeneDx Holdings Corp.
Company profileGeneDx Holdings Corp. (Ticker: WGSWW) is a leader in the genomics sector, specializing in genomic testing and precision medicine aimed at diagnosing rare and undiagnosed genetic conditions. Utilizing cutting-edge sequencing technologies and an extensive database of genetic knowledge, GeneDx equips healthcare providers with essential diagnostic tools that inform treatment strategies. The company’s diverse portfolio of genetic testing services and its strategic partnerships within the healthcare ecosystem position it favorably in an increasingly competitive market, underscoring its commitment…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NORTH TOWER, STAMFORD, CT
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer